SCHEMBL3846541

SCHEMBL3846541

Cc1nn(C(c2ccccc2)(c2ccccc2)c2ccccc2)cc1-c1ccc2ncnc(N3CCC(Oc4ccc(S(C)(=O)=O)cc4)CC3)c2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM4 P08173 3/20 0.45
CYP3A4 P08684 8/20 0.42
HPGD P15428 2/20 0.42
ALDH1A1 P00352 9/20 0.40
CYP1A2 P05177 8/20 0.40
CYP2C19 P33261 7/20 0.40
TSHR P16473 6/20 0.40
HIF1A Q16665 6/20 0.40
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
LMNA P02545 4/20 0.40
CYP2D6 P10635 3/20 0.40
KDM4E B2RXH2 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CLK4 Q9HAZ1 7/20 0.40
MAPK1 P28482 5/20 0.40
USP2 O75604 4/20 0.40
TP53 P04637 1/20 0.40
PDE3B Q13370 4/20 0.39
PDE3A Q14432 4/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3849596 0.88 CHRM4 (0.44) CHRM4
SCHEMBL3849227 0.87 CHRM4 (0.46) CHRM4CYP3A4HPGDALDH1A1CYP1A2
Hydrochloric Acid SCHEMBL3856292 0.80 CHRM4 (0.50) CHRM4CYP3A4HPGDALDH1A1CYP1A2
SCHEMBL3852758 0.79 CHRM4 (0.42) CHRM4CYP3A4HPGDMEN1KMT2A
SCHEMBL3849598 0.76 CHRM4 (0.39) CHRM4
SCHEMBL3845759 0.76 CYP3A4 (0.52) CYP3A4HPGDALDH1A1CYP1A2CYP2C19
SCHEMBL3845658 0.76 CHRM4 (0.56) CHRM4ALDH1A1PDE3BPDE3APDE10A
Hydrochloric Acid SCHEMBL3846061 0.75 CHRM4 (0.52) CHRM4CYP3A4ALDH1A1CYP1A2CYP2C19
SCHEMBL3855792 0.75 CHRM4 (0.45) CHRM4DYRK1A
SCHEMBL3855264 0.74 CHRM4 (0.42) CHRM4PDE3BPDE3APDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed